Literature DB >> 23661061

Outcome after elective neck dissection and observation for the treatment of the clinically node-negative neck (cN0) in squamous cell carcinoma of the oropharynx.

R Böscke1, B D Cakir, A S Hoffmann, S Wiegand, J Quetz, J E Meyer.   

Abstract

Optimal elective neck treatment in node-negative (cN0) oropharyngeal squamous cell carcinoma (OPSCC) patients is still controversially discussed. Retrospective chart review of 49 cT1-3 cN0 cM0 OPSCC patients, who had undergone surgical resection of the primary and either elective neck dissection (END) (n = 32) or observation (OBS) (n = 17) of the neck was performed. For systematic review of literature, Pubmed and EMBASE were searched for clinical studies including data on both END and OBS of the neck in cN0 OPSCC patients. Estimated 5-year overall survival (OS) rate was 82 % for END and 76 % for OBS [hazard ratio (HR) = 1.01]. Estimated 5-year disease-free survival (DFS) rate was 78 % for END and 67 % for OBS (HR = 1.79); 5-year DSS rate was 97 % (END) and 81 % (OBS) (HR = 2.22). None of the primary outcome variables (OS, DFS, DSS) revealed statistically significant effects for the treatment assignments. Hazard ratios implied an advantage for END. Systematic review of literature yielded only retrospective chart reviews and no data meeting our selection criteria for further data analysis. Due to lack of high-level evidence, the decision for END in cN0 OPSCC remains a diagnostic and therapeutic challenge. The demonstrated clinical equipoise would provide a solid basis for a multicentric, randomized trial.

Entities:  

Mesh:

Year:  2013        PMID: 23661061     DOI: 10.1007/s00405-013-2545-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  43 in total

1.  Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck Surgery.

Authors:  K Thomas Robbins; Garry Clayman; Paul A Levine; Jesus Medina; Roy Sessions; Ashok Shaha; Peter Som; Gregory T Wolf
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-07

2.  Early history of neck dissection.

Authors:  Alessandra Rinaldo; Alfio Ferlito; Carl E Silver
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-05-17       Impact factor: 2.503

Review 3.  A rationale for therapy of the N0 neck.

Authors:  H C Pillsbury; M Clark
Journal:  Laryngoscope       Date:  1997-10       Impact factor: 3.325

4.  Management of contralateral N0 neck in tonsillar squamous cell carcinoma.

Authors:  Young Chang Lim; Sei Young Lee; Jae-Yol Lim; Hyang Ae Shin; Jin Seok Lee; Bon Seok Koo; Se-Heon Kim; Eun Chang Choi
Journal:  Laryngoscope       Date:  2005-09       Impact factor: 3.325

5.  Evolution of the clinically negative neck.

Authors:  E M Skolnik; A H Katz; S P Becker; R Mantravadi; S Stal
Journal:  Ann Otol Rhinol Laryngol       Date:  1980 Nov-Dec       Impact factor: 1.547

6.  The topography of cervical lymph node metastases revisited: the histological findings in 526 sides of neck dissection from 439 previously untreated patients.

Authors:  J A Woolgar
Journal:  Int J Oral Maxillofac Surg       Date:  2007-01-18       Impact factor: 2.789

Review 7.  Use of decision analysis in planning a management strategy for the stage N0 neck.

Authors:  M H Weiss; L B Harrison; R S Isaacs
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1994-07

8.  Role of surgery in limited (T1-2, N0-1) cancers of the oropharynx.

Authors:  Rohan R Walvekar; Ryan J Li; William E Gooding; Michael K Gibson; Dwight Heron; Jonas T Johnson; Robert L Ferris
Journal:  Laryngoscope       Date:  2008-12       Impact factor: 3.325

Review 9.  Management of the clinically negative neck (N0) of supraglottic laryngeal carcinoma: a systematic review.

Authors:  J K Goudakos; K Markou; A Nikolaou; C Themelis; V Vital
Journal:  Eur J Surg Oncol       Date:  2008-05-12       Impact factor: 4.424

10.  Rationale for elective modified neck dissection.

Authors:  R M Byers; P F Wolf; A J Ballantyne
Journal:  Head Neck Surg       Date:  1988 Jan-Feb
View more
  5 in total

1.  Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.

Authors:  Shlomo A Koyfman; Nofisat Ismaila; Doug Crook; Anil D'Cruz; Cristina P Rodriguez; David J Sher; Damian Silbermins; Erich M Sturgis; Terance T Tsue; Jared Weiss; Sue S Yom; F Christopher Holsinger
Journal:  J Clin Oncol       Date:  2019-02-27       Impact factor: 44.544

2.  Tumoral Expression of CD44 and HIF1α Predict Stage I Oral Cavity Squamous Cell Carcinoma Outcome.

Authors:  Johannes Dunkel; Samuli Vaittinen; Petri Koivunen; Jussi Laranne; Markus J Mäkinen; Satu Tommola; Heikki Irjala
Journal:  Laryngoscope Investig Otolaryngol       Date:  2016-01-14

Review 3.  Current philosophy in the surgical management of neck metastases for head and neck squamous cell carcinoma.

Authors:  H Hakan Coskun; Jesus E Medina; K Thomas Robbins; Carl E Silver; Primož Strojan; Afshin Teymoortash; Phillip K Pellitteri; Juan P Rodrigo; Sandro J Stoeckli; Ashok R Shaha; Carlos Suárez; Dana M Hartl; Remco de Bree; Robert P Takes; Marc Hamoir; Karen T Pitman; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2014-06-30       Impact factor: 3.147

4.  Level IV neck dissection in cN0 HPV-negative oropharyngeal squamous cell carcinoma: a retrospective cohort study.

Authors:  Zirong Huo; Shuiting Fu; Chunyue Ma; Surui Sheng
Journal:  BMC Cancer       Date:  2022-05-12       Impact factor: 4.638

Review 5.  Treatment Options in Early Stage (Stage I and II) of Oropharyngeal Cancer: A Narrative Review.

Authors:  Giuseppe Meccariello; Andrea Catalano; Giovanni Cammaroto; Giannicola Iannella; Claudio Vicini; Sheng-Po Hao; Andrea De Vito
Journal:  Medicina (Kaunas)       Date:  2022-08-04       Impact factor: 2.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.